Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Benedictuson Dec 02, 2023 12:00am
234 Views
Post# 35764815

RE:RE:RE:RE:Various thoughts

RE:RE:RE:RE:Various thoughts
DJDawg wrote:
So teach me. Given the spike in shorts that you noted, does that mean some people out there may need to by up a moderate size group of shares to cover the short? So if the number of shares on the ask are not huge, then that could trigger a price spike?

Well I'm certainly not schooled enough on Bay Street shenanigans to consider myself a teacher...I'm merely throwing out my 2c worth of speculation based on the reported short activity and sp action. The latest shorts out are at 870k as of Nov 15th, so 273K were already covered and my guess is when we get the Nov 30th update, shorts outstanding will likely be under 500K. 

But back to your question. Yes, the shorts need to buy to cover their exposure. Prior to the LIFE announcement, outstanding shorts averaged 100K or below, and I'd guess by the end of December it will have settled back in that range again. Without any near term catalysts they can just cover incrementally, as part of a more subdued daily volume. I'd imagine only a sudden unexpected spike over .22 might prompt an immediate cover response. 

As an aside: a game the institutions used to play was shorting into a private placement, covering with the pp shares and then keeping the free warrants. This was exposed many years ago, so I imagine that loophole was closed. Does anyone know? 
<< Previous
Bullboard Posts
Next >>